6533b853fe1ef96bd12abf16
RESEARCH PRODUCT
False-Positive LSD Drug Screening Induced by a Mucolytic Medication
Gerd HafnerThomas KernJ. RöhrichWinfried PrellwitzJohannes LotzS. Zörntleinsubject
Drugmedicine.diagnostic_testbusiness.industrymedia_common.quotation_subjectBiochemistry (medical)Clinical BiochemistryPharmacologyClinical routineCraniocerebral traumaHomogeneousImmunoassaymedicineIngestionAmphetaminebusinessmedicine.drugmedia_commonLysergic acid diethylamidedescription
Since the early 1990s, the ingestion of lysergic acid diethylamide (LSD) as an inexpensive alternative to amphetamine derivatives has once again become widespread (1)(2). Consequently, screening of LSD has gained importance in clinical routine. The drug screening of a patient with a severe craniocerebral trauma showed a positive LSD screening by the homogeneous immunoassay CEDIA® DAU LSD (Boehringer Mannheim). In spite of the 3-h half-life of LSD in plasma (3), the drug screening remained positive for several days. These samples …
| year | journal | country | edition | language |
|---|---|---|---|---|
| 1998-07-01 | Clinical Chemistry |